Pilot Study of OXP005 to Assess Gastroduodenal Irritation

Trial Profile

Pilot Study of OXP005 to Assess Gastroduodenal Irritation

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Naproxen (Primary)
  • Indications Musculoskeletal pain
  • Focus Adverse reactions
  • Sponsors Oxford Pharmascience
  • Most Recent Events

    • 17 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 May 2015 Status changed from not yet recruiting to recruiting, according to an Oxford Pharmascience media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top